Abstract
MSR113 Inferring the Proportion of Durable Responders to Targeted Oncology Therapies in Combination Regimens Using Bayesian Parametric Mixture Survival Models
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have